Context Partners Fund’s Jasper Therapeutics JSPR Stock Holding History

Context Partners Fund’s Portfolio JSPR Stock Details JSPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$496K	Buy	+5,000	New	+$500K	0.11%	109

Other funds holding JSPR

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return

Sage Rock Capital Management New York $22.3M AUM 4.09% 1-Year Est. Return

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 50.48% 1-Year Est. Return

Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return

Dupont Capital Management Wilmington, Delaware $2.18M AUM 50.81% 1-Year Est. Return

Context Partners Fund's JSPR Position: Q3 2020 in Review

Context Partners Fund opened a new position in Jasper Therapeutics (JSPR) in Q3 2020: 5,000 shares worth $496K. The stake represents 0.11% of the portfolio and ranks #109 among its holdings.

42 funds tracked by Wall St. Rank hold JSPR as of Q3 2020.

Context Partners Fund held 5,000 shares of Jasper Therapeutics worth $496K as of Q3 2020.
Jasper Therapeutics was a new Context Partners Fund position in Q3 2020.
Jasper Therapeutics made up 0.11% of Context Partners Fund's portfolio in Q3 2020, its #109 holding.
42 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q3 2020.

Based on Context Partners Fund's 13F filing for Q3 2020, filed 16 Nov 2020.